Skip to main content
. 2022 Nov 24;12:995991. doi: 10.3389/fonc.2022.995991

Table 2A.

Multivariable analysis for all-cause mortality (ACM).

Variable Hazard ratio (HR) 95% CI Low 95% CI High p
Age (continuous) 1.03 1.02 1.03 <0.001
Sex (female vs. male) 1.10 0.89 1.35 0.38
Race (other vs. AA) 1.17 0.86 1.46 0.41
BMI (continuous) 0.99 0.98 1.01 0.25
CAD (no vs. yes) 1.25 0.10 1.56 0.055
DM (no vs. yes) 1.18 0.91 1.53 0.211
Surgery Type (RN vs. PN) 1.14 0.92 1.41 0.25
Tumor stage (reference = Stage 1) <0.001
 Stage 2 vs. Stage 1 1.66 1.12 2.48 0.013
 Stage 3 vs. Stage 1 2.25 1.73 2.93 <0.001
 Stage 4 vs. Stage 1 1.32 1.07 1.64 <0.001
Metastasis (no vs. yes) 2.00 1.58 2.53 <0.001
Last eGFR < 45 ml/min/1.73m² (no vs. yes) 1.35 1.11 1.64 0.003
NLR ≥ 2.27 (no vs. yes) 1.32 1.07 1.64 0.011
PLR ≥ 165 (no vs. yes) 1.07 0.84 1.38 0.569
AST/ALT ≥ 2.72 (no vs. yes) 2.04 1.65 2.52 <0.001